{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:13:33Z","timestamp":1788509613770,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2127"],"award-info":[{"award-number":["JPMJSP2127"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23ak0101192h0001"],"award-info":[{"award-number":["23ak0101192h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02786"],"award-info":[{"award-number":["22H02786"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xphs.2026.104335","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:11:36Z","timestamp":1779203496000},"page":"104335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Small intestine-permeable cyclic peptide-mediated enhancement of Fc-fusion protein absorption in mice"],"prefix":"10.1016","volume":"115","author":[{"given":"Shoma","family":"Chikamatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosei","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumio","family":"Ohtsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8862-471X","authenticated-orcid":false,"given":"Shingo","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2026.104335_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"},{"issue":"1","key":"10.1016\/j.xphs.2026.104335_bib0002","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s42003-022-03787-x","article-title":"Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life","volume":"5","author":"Gj\u00f8lberg","year":"2022","journal-title":"Commun Biol"},{"issue":"5","key":"10.1016\/j.xphs.2026.104335_bib0003","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4161\/mabs.3.5.16983","article-title":"Neonatal Fc receptor and IgG-based therapeutics","volume":"3","author":"Kuo","year":"2011","journal-title":"MAbs"},{"issue":"10","key":"10.1016\/j.xphs.2026.104335_bib0004","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.tips.2018.07.007","article-title":"Targeting FcRn to generate antibody-based therapeutics","volume":"39","author":"Ward","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104335_bib0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40259-021-00471-0","article-title":"Recent achievements and challenges in prolonging the serum half-lives of therapeutic IgG antibodies through fc engineering","volume":"35","author":"Ko","year":"2021","journal-title":"BioDrugs"},{"key":"10.1016\/j.xphs.2026.104335_bib0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2014.06.022","article-title":"In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin","volume":"189","author":"Nielsen","year":"2014","journal-title":"J Control Rel"},{"key":"10.1016\/j.xphs.2026.104335_bib0007","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/acs.molpharmaceut.5c00902","article-title":"Small intestine-permeable cyclic peptide-based technology enables efficient oral delivery and glycemic efficacy of zinc-stabilized insulin hexamer and its analogs in diabetic mice","volume":"23","author":"Chikamatsu","year":"2026","journal-title":"Mol Pharm"},{"issue":"467","key":"10.1016\/j.xphs.2026.104335_bib0008","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar7047","article-title":"Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist","volume":"10","author":"Buckley","year":"2018","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.xphs.2026.104335_bib0009","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/pharmaceutics11020078","article-title":"Intestinal permeation enhancers for oral delivery of macromolecules: a comparison between salcaprozate sodium (SNAC) and sodium caprate (C(10))","volume":"11","author":"Twarog","year":"2019","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.xphs.2026.104335_bib0010","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1080\/17425247.2021.1942838","article-title":"Transient permeation enhancer\u00ae (TPE\u00ae) technology for oral delivery of octreotide: a technological evaluation","volume":"18","author":"Brayden","year":"2021","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10.1016\/j.xphs.2026.104335_bib0011","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/pharmaceutics16010047","article-title":"Oral absorption of middle-to-large molecules and its improvement, with a focus on new modality drugs","volume":"16","author":"Asano","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6427","key":"10.1016\/j.xphs.2026.104335_bib0012","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1126\/science.aau2277","article-title":"An ingestible self-orienting system for oral delivery of macromolecules","volume":"363","author":"Abramson","year":"2019","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.xphs.2026.104335_bib0013","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41587-021-01024-0","article-title":"Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors","volume":"40","author":"Abramson","year":"2022","journal-title":"Nat Biotechnol"},{"issue":"8042","key":"10.1016\/j.xphs.2026.104335_bib0014","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41586-024-08202-5","article-title":"Cephalopod-inspired jetting devices for gastrointestinal drug delivery","volume":"636","author":"Arrick","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xphs.2026.104335_bib0015","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jconrel.2017.07.037","article-title":"Identification of cyclic peptides for facilitation of transcellular transport of phages across intestinal epithelium in vitro and in vivo","volume":"262","author":"Yamaguchi","year":"2017","journal-title":"J Control Rel"},{"issue":"4","key":"10.1016\/j.xphs.2026.104335_bib0016","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1021\/acs.molpharmaceut.0c01010","article-title":"Oral coadministration of Zn-insulin with D-form small intestine-permeable cyclic peptide enhances its blood glucose-lowering effect in mice","volume":"18","author":"Ito","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2026.104335_bib0017","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104335_bib0018","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/imr.12349","article-title":"Human IgG4: a structural perspective","volume":"268","author":"Davies","year":"2015","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.xphs.2026.104335_bib0019","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/antib6030012","article-title":"Functional, biophysical, and structural characterization of human IgG1 and IgG4 fc variants with ablated immune functionality","volume":"6","author":"Tam","year":"2017","journal-title":"Antibodies"},{"issue":"1","key":"10.1016\/j.xphs.2026.104335_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13238-017-0473-8","article-title":"IgG fc engineering to modulate antibody effector functions","volume":"9","author":"Wang","year":"2018","journal-title":"Protein Cell"},{"issue":"3","key":"10.1016\/j.xphs.2026.104335_bib0021","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.diabet.2017.10.007","article-title":"Durability of protective effect of dulaglutide on pancreatic \u03b2-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure","volume":"44","author":"Kimura","year":"2018","journal-title":"Diabetes Metab"},{"issue":"2","key":"10.1016\/j.xphs.2026.104335_bib0022","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/19420862.2015.1008353","article-title":"The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity","volume":"7","author":"Abdiche","year":"2015","journal-title":"MAbs"},{"issue":"6504","key":"10.1016\/j.xphs.2026.104335_bib0023","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/372379a0","article-title":"Crystal structure of the complex of rat neonatal fc receptor with Fc","volume":"372","author":"Burmeister","year":"1994","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.xphs.2026.104335_bib0024","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1097-2765(01)00230-1","article-title":"Crystal structure at 2.8 A of an FcRn\/heterodimeric fc complex: mechanism of pH-dependent binding","volume":"7","author":"Martin","year":"2001","journal-title":"Mol Cell"},{"issue":"21","key":"10.1016\/j.xphs.2026.104335_bib0025","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1182\/blood.V120.21.2219.2219","article-title":"Cellular uptake of rFVIIIFc in liver is primarily contributed by sinusoidal endothelial cells","volume":"120","author":"Tan","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.xphs.2026.104335_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124930","article-title":"FcRn rescues recombinant factor VIII Fc fusion protein from a VWF independent FVIII clearance pathway in mouse hepatocytes","volume":"10","author":"van der Flier","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.xphs.2026.104335_bib0027","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1210\/en.2006-0153","article-title":"Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats","volume":"148","author":"Vahl","year":"2007","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.xphs.2026.104335_bib0028","doi-asserted-by":"crossref","first-page":"E376","DOI":"10.1152\/ajpendo.00565.2012","article-title":"Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways","volume":"305","author":"Nishizawa","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.xphs.2026.104335_bib0029","article-title":"Mechanisms of action and therapeutic applications of GLP-1 and dual GIP\/GLP-1 receptor agonists","volume":"15","author":"Liu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492600184X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492600184X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:31:43Z","timestamp":1788507103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235492600184X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S002235492600184X"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104335","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small intestine-permeable cyclic peptide-mediated enhancement of Fc-fusion protein absorption in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104335"}}